Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H30N3.Cl |
| Molecular Weight | 407.979 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)=C3C=CC(C=C3)=[N+](C)C
InChI
InChIKey=ZXJXZNDDNMQXFV-UHFFFAOYSA-M
InChI=1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1
| Molecular Formula | C25H30N3 |
| Molecular Weight | 372.5258 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24118276 | http://www.webmd.com/drugs/2/drug-4397/gentian-violet-topical/detailsCurator's Comment: Description was created based on several sources, including https://www.drugbank.ca/drugs/DB00406
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24118276 | http://www.webmd.com/drugs/2/drug-4397/gentian-violet-topical/details
Curator's Comment: Description was created based on several sources, including https://www.drugbank.ca/drugs/DB00406
Gentian violet ((GV) hexamethyl pararosaniline, also known as crystal violet, methyl violet) is a triphenylmethane dye with anti-bacterial, anti-fungal, anti-helminithic, anti-trypanosomal, anti-angiogenic and anti-tumor properties. GV has a lengthy history and has been used successfully as monotherapy and an adjunct to treatment in a variety of diseases. Gentian violet interacts with negatively charged components of bacterial cells including the lipopolysaccharide (on the cell wall), the peptidoglycan and DNA. A similar cell penetration and DNA binding process is thought to take place for fungal cells as well. Because Gentian violet is a mutagen and mitotic poison, cell growth is consequently inhibited. A photodynamic action of gentian violet, apparently mediated by a free-radical mechanism, has recently been described in bacteria and in the protozoan T. cruzi. Evidence also suggests that gentian violet dissipates the bacterial (and mitochondrial) membrane potential by inducing permeability. This is followed by respiratory inhibition. This anti-mitochondrial activity might explain gentian violet's efficacy towards both bacteria and yeast with relatively mild effects on mammalian cells.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24118276
Curator's Comment: Synthesis of Gentian violet was attributed French chemist Charles Lauth in 1861 under the name of ‘Violet de Paris
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2366922 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18579783 |
22.13 nM [EC50] | ||
Target ID: CHEMBL2364041 |
|||
Target ID: CHEMBL368 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21478242 |
30.6 µM [IC50] | ||
Target ID: CHEMBL2364041 |
|||
Target ID: Thioredoxin reductase 2, fungal Sources: https://www.ncbi.nlm.nih.gov/pubmed/24118276 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | GENTIAN VIOLET Approved UseTopical gentian violet is used to treat some types of fungus infections inside the mouth (thrush) and of the skin. |
|||
| Preventing | GENTIAN VIOLET Approved UseGentian violet has weak antibacterial effects and may be used on minor cuts and scrapes to prevent infection. |
Doses
| Dose | Population | Adverse events |
|---|---|---|
1 % single, ophthalmic |
unhealthy, 55 years |
Other AEs: Keratoconjunctivitis... |
2 % 10 times / day multiple, oral Dose: 2 %, 10 times / day Route: oral Route: multiple Dose: 2 %, 10 times / day Sources: |
unhealthy, infant |
Disc. AE: Swollen tongue, Oral mucosa pain... AEs leading to discontinuation/dose reduction: Swollen tongue Sources: Oral mucosa pain |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Keratoconjunctivitis | 1 % single, ophthalmic |
unhealthy, 55 years |
|
| Oral mucosa pain | Disc. AE | 2 % 10 times / day multiple, oral Dose: 2 %, 10 times / day Route: oral Route: multiple Dose: 2 %, 10 times / day Sources: |
unhealthy, infant |
| Swollen tongue | Disc. AE | 2 % 10 times / day multiple, oral Dose: 2 %, 10 times / day Route: oral Route: multiple Dose: 2 %, 10 times / day Sources: |
unhealthy, infant |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| yes [Activation 15 uM] | ||||
| yes [Activation 2 uM] | ||||
| yes [Activation 3.2 uM] | ||||
| yes [Activation 3.9 uM] | ||||
| yes [Activation 6.3 uM] | ||||
| yes [Activation 7.6 uM] | ||||
| yes [Activation 7.9 uM] | ||||
| yes [IC50 7.7 uM] | ||||
| yes |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/23611293/ |
Sample Use Guides
Clean the affected area and apply a small amount of this product on the
area 1 to 3 times daily. May be covered with a sterile bandage.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18242063
Gentian violet showed the most potent activity against all Candida isolates tested (MIC range, MIC for 50% of the organisms (MIC(50)) and MIC for 90% of the organisms (MIC(90)) of 0.03-0.25 ug/mL, 0.06 ug/mL and 0.1 2 ug/mL, respectively).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:54:09 GMT 2025
by
admin
on
Wed Apr 02 06:54:09 GMT 2025
|
| Record UNII |
J4Z741D6O5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
||
|
EPA PESTICIDE CODE |
39502
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
||
|
CFR |
21 CFR 589.1000
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D005840
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
11057
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
100000080908
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
4366
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
208-953-6
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
GENTIAN VIOLET
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | Other names: Crystal violet, gentian violet. Description: A dark green powder or greenish, glistening pieces having a metallic lustre; odourless or almost odourless. Solubility: Sparingly soluble in water; soluble in ethanol (~750 g/l) TS and glycerol R; practically insoluble in ether R. Category: Anti-infective drug. Storage: Methylrosanilinium chloride should be kept in a tightly closed container, protected from light. Requirements: Methylrosanilinium chloride contains not less than 96.0% and not more than the equivalent of 101.0% of C25H30ClN3, calculated with reference to the anhydrous substance. | ||
|
DTXSID5020653
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
4138
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
m5700
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
113
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL459265
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
SUB08875MIG
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
Gentian Violet
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
41688
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
C548657
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
CRYSTAL VIOLET
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
DBSALT000604
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
4778
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | RxNorm | ||
|
C61776
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
3090
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
1290002
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
J4Z741D6O5
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
J4Z741D6O5
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY | |||
|
548-62-9
Created by
admin on Wed Apr 02 06:54:09 GMT 2025 , Edited by admin on Wed Apr 02 06:54:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |